Exon Skipping and Inclusion Therapies (eBook, PDF)

Methods and Protocols
Redaktion: Yokota, Toshifumi; Maruyama, Rika

• Format: PDF

Produktbeschreibung

This book presents a comprehensive collection of detailed state-of-the-art exon skipping and splices modulation protocols. Chapters detail 14 genetic diseases, AON-mediated therapies, and CRISPR/Cas9-mediated gene editing therapies. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.

Authoritative and cutting-edge, Exon Skipping and Inclusion Therapies: Methods and Protocols aims to help researchers initiate the development of next-generation therapies.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Springer New York
• Seitenzahl: 569
• Erscheinungstermin: 31. August 2018
• Englisch
• ISBN-13: 9781493986514
• Artikelnr.: 64701758

Inhaltsangabe

Invention and Early History of Exon Skipping and Splice Modulation.- An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.- Recent Advances and Clinical Applications of Exon Inclusion for Spinal Muscular Atrophy.- Nusinersen in the Treatment of Spinal Muscular Atrophy.- Tips to Design Effective Splice-switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion.- Antisense Oligonucleotide Targeting of 3'UTR of mRNA for Expression Knockdown.- Quantitative Evaluation of Exon Skipping in Immortalized Muscle Cells In Vitro.- Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-m Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.- In vitro Multi-exon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.- Creation of DMD Muscle Cell Model using CRISPR-Cas9 Genome Editing toTest the Efficacy of Antisense-mediated Exon Skipping.- In vitro Evaluation of Exon Skipping in Disease Specific iPSC-derived Myocytes.- Restoration of Dystrophin Protein Expression by Exon Skipping utilizing CRISPR-Cas9 in Myoblasts Derived from DMD Patient iPS Cells.- Skipping of Duplicated Dystrophin Exons: in vitro Induction and Assessment.- In Vivo Evaluation of Dystrophin Exon Skipping in mdx Mice.- Exon 51 Skipping Quantification by Digital Droplet PCR in del52hDMD/mdx Mice.- Systemic Injection of Peptide-PMOs into Humanized DMD Mice and Detection by RT-PCR and ELISA.- In vivo Evaluation of Single- and Multi-exon Skipping in mdx52 Mice.- A Novel Zebrafish Model for Assessing In Vivo Delivery of Morpholino Oligomers.- Validation and Detection of Exon Skipping Boosters in DMD Patient Cell Models and mdx Mouse.- Use of Glucose/Fructose to Enhance the Exon Skipping Efficacy.- Systemic Intravenous Administration of Antisense Therapeutics forCombinatorial Dystrophin and Myostatin Exon Splice Modulation.- The Assembly of Fluorescently Labeled Peptide-oligonucleotide Conjugates via Orthogonal Ligation Strategies.- In vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.- Use of Tricyclo-DNA Antisense Oligonucleotides for Exon Skipping.- Optimization of 2 ,4 -BNA/LNA-based Oligonucleotides For Splicing Modulation in vitro.- Pre-Mrna Splicing Modulation by Antisense Oligonucleotides.- In vitro Evaluation of Antisense-mediated Exon Inclusion for Spinal Muscular Atrophy.- Systemic Injection of Antisense oligos into SMA Mice and Evaluation.- Exon Skipping using Antisense Oligonucleotides for Laminin-alpha2-deficient Muscular Dystrophy.- Exon Skipping by Ultrasound-enhanced Delivery of Morpholino with Bubble Liposomes for Myotonic Dystrophy Model Mice.- Dysferlin Exon 32 Skipping in Patient Cells.- Morpholino-mediated Exon Skipping Targeting Human ACVR1/ALK2 for Fibrodysplasia Ossificans Progressiva.- Exon Skipping of Fc RIbeta for Allergic Diseases.- Antisense Oligonucleotide Design and Evaluation of Splice-modulating Properties Using Cell-based Assays.- Antisense-mediated Splice Modulation to Reframe Transcripts.- Morpholino-mediated Exon Inclusion for SMA.